Home » Topics » BioWorld Science

BioWorld Science
RSS

PanOptica initiates phase I/II trial of PAN-90806 in wet AMD

May 24, 2018

Plant Advanced Technologies patents quinic acid derivatives

May 24, 2018

Center for Translational Drug Development synthesizes ROCK1/2 inhibitors

May 24, 2018

Hefei Co-Source Pharmaceuticals and Anhui Blooming Drug Safety Evaluation patent steroids

May 24, 2018

RARI-049, a novel Nampt inhibitor for treating pulmonary hypertension

May 24, 2018

Carna Biosciences and Kitasato Institute discover antimalarials

May 24, 2018

Ache Laboratorios Farmaceuticos divulges melatonin MT1 and MT2 receptor agonists

May 24, 2018

New hedgehog signaling inhibitors presented by e-Therapeutics

May 24, 2018

IFB-088 to enter phase I clinical testing

May 24, 2018

FDA accepts supplemental BLA and grants priority review for pediatric use of Coagadex

May 24, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...